Profile data is unavailable for this security.
About the company
Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. The Company has developed NGS technology (Sequencing Engine), which is a platform technology for its products. The core of its Sequencing Engine consists of proprietary chemistry, including novel chemical compounds, polymers, and enzymes. Its active product development pipeline consists of two products, each of which is designed to leverage the Sequencing Engine and purpose-built to address different applications. Its first product, the G4 Sequencing Platform (G4), targets the NGS market. Its second product in development, G4X Spatial Sequencer, which leverages its sequencing technology, applying it as an in-situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. The Company is also engaged in developing PX, which is a development-stage multiomics platform.
- Revenue in USD (TTM)2.91m
- Net income in USD-94.82m
- Incorporated2016
- Employees255.00
- LocationSingular Genomics Systems Inc3010 SCIENCE PARK ROADSAN DIEGO 92121United StatesUSA
- Phone+1 (858) 333-7830
- Fax+1 (302) 531-3150
- Websitehttps://singulargenomics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mink Therapeutics Inc | 0.00 | -22.46m | 31.21m | 31.00 | -- | -- | -- | -- | -0.6538 | -0.6538 | 0.00 | -0.5219 | 0.00 | -- | -- | 0.00 | -172.59 | -- | -2,317.47 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 19.77 | -- | -- | -- |
| Dare Bioscience Inc | 2.81m | -30.16m | 31.54m | 23.00 | -- | -- | -- | 11.23 | -0.3444 | -0.3444 | 0.032 | -0.0505 | 0.0863 | -- | 2.12 | 122,082.20 | -92.65 | -109.51 | -463.87 | -246.26 | -- | -- | -1,074.17 | -1,104.55 | -- | -- | -- | -- | -71.92 | -- | 2.54 | -- | 121.37 | -- |
| Brainstorm Cell Therapeutics Inc | 0.00 | -17.19m | 31.92m | 29.00 | -- | -- | -- | -- | -0.4079 | -0.4079 | 0.00 | -0.0803 | 0.00 | -- | -- | 0.00 | -271.62 | -117.19 | -- | -231.65 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 29.18 | -- | -45.34 | -- |
| Acurx Pharmaceuticals Inc | 0.00 | -14.58m | 31.96m | 4.00 | -- | 6.26 | -- | -- | -1.14 | -1.14 | 0.00 | 0.3226 | 0.00 | -- | -- | 0.00 | -170.64 | -- | -243.33 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -20.55 | -- | -- | -- |
| RenovoRx Inc | 0.00 | -10.23m | 32.21m | 8.00 | -- | -- | -- | -- | -1.01 | -1.01 | 0.00 | -0.2805 | 0.00 | -- | -- | 0.00 | -234.38 | -- | -317.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -3.47 | -- | -- | -- |
| Viracta Therapeutics Inc | 0.00 | -51.06m | 32.40m | 40.00 | -- | 2.51 | -- | -- | -1.32 | -1.32 | 0.00 | 0.4686 | 0.00 | -- | -- | 0.00 | -66.88 | -86.35 | -97.91 | -106.38 | -- | -- | -- | -11,853.94 | -- | -141.21 | 0.5798 | -- | -- | -- | -3.78 | -- | -- | -- |
| LianBio - ADR | 0.00 | -87.98m | 32.55m | 163.00 | -- | 0.1595 | -- | -- | -0.8195 | -0.8195 | 0.00 | 1.89 | 0.00 | -- | -- | 0.00 | -28.62 | -- | -35.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 43.82 | -- | -- | -- |
| Surrozen Inc | 0.00 | -43.04m | 32.72m | 42.00 | -- | 0.5563 | -- | -- | -21.35 | -21.35 | 0.00 | 18.39 | 0.00 | -- | -- | 0.00 | -63.52 | -- | -72.56 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | -19.55 | -- | -- | -- |
| Fortress Biotech Inc | 84.51m | -68.67m | 32.89m | 186.00 | -- | 1.14 | -- | 0.3892 | -8.88 | -8.88 | 10.29 | 1.49 | 0.366 | 2.19 | 3.89 | 454,371.00 | -66.76 | -52.50 | -117.74 | -99.46 | 68.45 | 63.17 | -182.40 | -236.94 | 1.26 | -11.31 | 0.9758 | -- | 11.58 | 25.75 | 27.42 | -- | -9.37 | -- |
| Singular Genomics Systems Inc | 2.91m | -94.82m | 33.11m | 255.00 | -- | 0.1847 | -- | 11.37 | -1.30 | -1.30 | 0.04 | 2.42 | 0.0098 | 0.2182 | 3.94 | 11,415.69 | -31.96 | -- | -33.80 | -- | -19.17 | -- | -3,257.30 | -- | 9.77 | -- | 0.0474 | -- | 280.52 | -- | -4.34 | -- | -- | -- |
| Promis Neurosciences Inc | 0.00 | -13.21m | 33.94m | 6.00 | -- | 9.01 | -- | -- | -1.22 | -1.22 | 0.00 | 0.1987 | 0.00 | -- | -- | 0.00 | -128.63 | -144.28 | -552.70 | -262.23 | -- | -- | -- | -2,271,047.00 | -- | -- | 0.00 | -- | -- | -- | 26.85 | -- | -- | -- |
| Spruce Biosciences Inc | 10.09m | -47.92m | 34.50m | 29.00 | -- | 0.4496 | -- | 3.42 | -1.26 | -1.26 | 0.2622 | 1.86 | 0.1064 | -- | -- | 347,896.60 | -50.55 | -41.24 | -62.77 | -46.49 | -- | -- | -474.96 | -1,774.39 | -- | -107.65 | 0.0418 | -- | -- | -- | -3.77 | -- | -- | -- |
| Rapid Micro Biosystems Inc | 23.10m | -51.90m | 34.50m | 193.00 | -- | 0.3252 | -- | 1.49 | -1.20 | -1.20 | 0.5355 | 2.48 | 0.1535 | 1.37 | 4.34 | 119,663.20 | -34.49 | -- | -38.20 | -- | -22.59 | -- | -224.73 | -- | 5.62 | -- | 0.0028 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
| IGC Pharma Inc | 1.22m | -14.15m | 34.60m | 61.00 | -- | 3.66 | -- | 28.46 | -0.2479 | -0.2479 | 0.0217 | 0.142 | 0.0776 | 0.2084 | 7.09 | 19,934.43 | -90.30 | -33.35 | -100.90 | -35.84 | 51.40 | 8.74 | -1,163.24 | -410.26 | 0.8564 | -- | 0.0153 | -- | 129.47 | -16.11 | 23.38 | -- | 25.28 | -- |
| DURECT Corp | 8.55m | -27.62m | 35.07m | 58.00 | -- | 2.32 | -- | 4.10 | -1.12 | -1.12 | 0.3257 | 0.4873 | 0.1624 | 0.7927 | 3.65 | 147,379.30 | -52.47 | -37.34 | -124.79 | -53.44 | 79.91 | 91.83 | -323.16 | -139.11 | 1.20 | -55.63 | 0.5299 | -- | -55.67 | -10.96 | 21.82 | -- | -10.98 | -- |
Data as of May 09 2024. Currency figures normalised to Singular Genomics Systems Inc's reporting currency: US Dollar USD
24.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Deerfield Management Co. LPas of 09 Aug 2023 | 5.39m | 7.29% |
| QVIDTVM Management LLCas of 31 Dec 2023 | 2.32m | 3.14% |
| UBS Securities LLCas of 31 Dec 2023 | 2.21m | 2.99% |
| Perceptive Advisors LLCas of 31 Dec 2023 | 2.13m | 2.88% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.86m | 2.51% |
| Casdin Capital LLCas of 31 Dec 2023 | 1.32m | 1.79% |
| BMO Asset Management Corp.as of 31 Dec 2023 | 982.50k | 1.33% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 663.24k | 0.90% |
| Verition Fund Management LLCas of 31 Dec 2023 | 475.00k | 0.64% |
| Geode Capital Management LLCas of 31 Dec 2023 | 460.64k | 0.62% |
More ▼
Data from 31 Dec 2023 - 15 Mar 2024Source: FactSet Research Systems Inc.
